Differences in colloidal structure of PEGylated nanomaterials dictate the likelihood of accelerated blood clearance

Journal of Pharmaceutical Sciences

Volumn 100, Issue 11, 2011, Pages 5069-5077

  Kaminskas, Lisa M ^a   Mcleod, Victoria M ^a   H Porter, Christopher J ^a   Boyd, Ben J ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Accelerated blood clearance; Clearance; Formulation; Lipids lipoproteins; Liposome; Micelle; Pharmacokinetics; Polyethylene glycol

Indexed keywords

CHOLESTEROL; IMMUNOGLOBULIN M; LIPOSOME; MACROGOL; NANOMATERIAL;

ACCELERATED BLOOD CLEARANCE; ARTICLE; DISPERSION; DRUG DELIVERY SYSTEM; ELIMINATION REACTION; IMMUNOGLOBULIN PRODUCTION; MALE; MICELLE; NONHUMAN; PARTICLE SIZE; PLASMA CLEARANCE; RAT; REPEAT PROCEDURE;

EID: 80053275944     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22682     Document Type: Article

References (20)

1. Laverman P, Brouwers AH, Dams ETM, Oyen WJG, Storm G, Rooijen NV, Corstens FHM, Boerman OC. 2000. Preclinical and clinical evidence for disappearance of long-circulating characteristics of polyethylene glycol liposomes at low lipid dose. J Pharmacol Exp Ther 293:996-1001.
2. Dams E, Laverman P, Oyen W, Storm G, Scherphof G, van der Meer J, Corstens F, Boerman O. 2000. Accelerated blood clearance and altered biodistribution of repeat injections of sterically stabilized liposomes. J Pharmacol Exp Ther 292:1071-1079.
3. Ishida T, Maeda R, Ichihara M, Irimura K, Kiwada H. 2003. Accelerated clearance of PEGylated liposomes in rats after repeated injections. J Control Release 88:35-42.
4. Wang XY, Ishida T, Ichihara M, Kiwada H. 2005. Influence of the physicochemical properties of liposomes on the accelerated blood clearance phenomenon in rats. J Control Release 104:91-102.
5. Koide H, Asai T, Hatanaka K, Akai S, Ishii T, Kenjo E, Ishida T, Kiwada H, Tsukada H, Oku N. 2010. T cell-independent B cell response is responsible for ABC phenomenon induced by repeated injection of PEGylated liposomes. Int J Pharm 392:218-223.
6. Ishida T, Atobe K, Wang XY, Kiwada H. 2006. Accelerated blood clearance of PEGylated liposomes upon repeated injections: Effect of doxorubicin-encapsulation and high-dose first injection. J Control Release 115:251-258.
7. Laverman P, Carstens MG, Boerman OC, Dams ETM, Oyen WJG, Rooijen NV, Corstens FHM, Storm G. 2001. Factors affecting the accelerated blood clearance of polyethylene glycol-liposomes upon repeated injection. J Pharmacol Exp Ther 298:607-612.
8. Wang XY, Ishida T, Kiwada H. 2007. Anti-PEG IgM elicited by injection of liposomes is involved in the enhanced blood clearance of a subsequent dose of PEGylated liposomes. J Control Release 119:236-244.
9. Ishida T, Ichihara M, Wang X, Yamamoto K, Kimura J, Majima E, Kiwada H. 2006. Injection of PEGylated liposomes in rats elicits PEG-specific IgM, which is responsible for rapid elimination of a second dose of PEGylated liposomes. J Control Release 112:15-25.
10. Koide H, Asai T, Hatanaka K, Urakami T, Ishii T, Kenjo E, Nishihara M, Yokoyama M, Ishida T, Kiwada H, Oku N. 2008. Particle size-dependent triggering of accelerated blood clearance phenomenon. Int J Pharm 362:197-200.
11. Ishida T, Harada M, Wang XY, Ichihara M, Irimura K, Kiwada H. 2005. Accelerated blood clearance of PEGylated liposomes following preceding liposome injection: Effects of lipid dose and PEG surface-density and chain length of the first-dose liposomes. J Control Release 105:305-317.
12. Semple SC, Harasym TO, Clow KA, Ansell SM, Klimuk SK, Hope MJ. 2005. Immunogenicity and rapid blood clearance of liposomes containing polyethylene glycol-lipid conjugates and nucleic acid. J Pharmacol Exp Ther 312:1020-1026.
13. Ishihara T, Takeda M, Sakamoto H, Kimoto A, Kobayashi C, Takasaki N, Yuki K, Tanaka K, Takenaga M, Igarashi R, Maeda T, Yamakawa N, Okamoto Y, Otsuka M, Ishida T, Kiwada H, Mizushima Y, Mizushima T. 2009. Accelerated blood clearance phenomenon upon repeated injection of PEG-modified PLA-nanoparticles. Pharm Res 26:2270-2279.
14. Maeda H, Bharate GY, Daruwalla J. 2008. Polymeric drugs for tumor-targeted drug delivery based on EPR-effect. Eur J Pharm Biopharm 71:409-419.
15. Kaminskas LM, Kota J, McLeod VM, Kelly BD, Karellas P, Porter CJ. 2009. PEGylation of polylysine dendrimers improves absorption and lymphatic targeting following SC administration in rats. J Control Release 140:108-116.
16. Ashok B, Arleth L, Hjelm RP, Rubinstein I, Onyuksel H. 2004. In vitro characterization of PEGylated phospholipid micelles for improved drug solubilization: Effects of PEG chain length and PC incorporation. J Pharm Sci 93:2476-2487.
17. Boyd BJ, Kaminskas LM, Karellas P, Krippner G, Lessene R, Porter CJH. 2006. Cationic poly-l-lysine dendrimers: Pharmacokinetics, biodistribution and evidence for metabolism and bioresorption after intravenous administration in rats. Mol Pharm 3:614-627.
18. Lukyanov AN, Gao Z, Mazzola L, Torchilin VP. 2002. Polyethylene glycol-diacyllipid micelles demonstrate increased accumulation in subcutaneous tumors in mice. Pharm Res 19:1424-1429.
19. Ichihara M, Shimizu T, Imoto A, Hashiguchi Y, Uehara Y, Ishida T, Kiwada H. 2011. Anti-PEG IgM response against PEGylated liposomes in mice and rats. Pharmaceutics 3:1-11.
20. Edwards K, Johnsson M, Karlsson G, Silvander M. 1997. Effect of polyethylene glycol-phospholipids on aggregate structure in preparations of small unilamellar liposomes. Biophys J 73:258-266.